| n = 335 |
---|---|
Male / Female, n (%) | 233 (70) / 102 (30) |
Age (years) | 62 ± 11 |
BMI (kg/m2) | 24.8 ± 3.8 |
Hypertension, n (%) | 224Â (67) |
Diabetes mellitus, n (%) | 92Â (28) |
 HbA1c (%) | 6.1 ± 0.9 |
Current smoking, n (%) | 26 (7.8) |
Dyslipidemia, n (%) | 269 (80) |
eGFR (ml/min/1.73 m2) | 69 ± 17 |
 CKD Stage 3≥, n (%) | 89 (27) |
Number of risk factors | 4.0 ± 1.5 |
Cardiovascular disease, n (%) | 100 (30) |
 Coronary artery disease | 87 (26) |
 Cerebral infarction | 12 (3.6) |
 Aortic dissection/aortic aneurysm | 4 (1.2) |
 Peripheral arterial disease | 3 (0.9) |
Concomitant drug, n (%) | |
 Anti-platelets | 101 (30) |
 ACEs/ARBs | 191 (57) |
 β blockers | 77 (23) |
 Calcium channel blockers | 183(55) |
 Lipid-modifying drugs | 201(60) |
  Statins | 179 (53) |
  Fibrates | 8 (2.4) |
  Ezetimibe | 15 (4.5) |